| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 16, 2006
Accepted on March 1, 2007
Unit of Lipids and Atherosclerosis (R.M., F.P.-J., C.M., P.P-M., P.G., Y.J-G., J.D., J.A.M., J.-L.M.), Hospital Universitario Reina Sofia, 14004 Cordoba, Spain; and Nutrition and Genomics Laboratory (T.T., J.M.O.), United States Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Massachusetts 02111-1524
* To whom correspondence should be addressed. E-mail: jlopezmir{at}uco.es.
Background: Apolipoprotein A5 (APOA5) plays an important role in plasma triacylglycerol (TG) homeostasis. Five polymorphisms (1131T>C, c.-3A>G, c.56C>G, IVS3+476G>A, c.1259T>C) in the APOA5 gene define three common haplotypes (APOA5*1, APOA5*2 and APOA5*3) in Caucasian individuals. Our aim was to determine whether these haplotypes could modulate the postprandial response in young healthy males.
Design and methods: Eighty-eight APO E3/3 volunteers [67 with (-1131T and 56C) APOA5*1 haplotype, 12 with (-1131C and 56C) APOA5*2 haplotype and nine with (-1131T and 56G) APOA5*3 haplotype] underwent a fat-load test consisting of the consumption of 1 g of fat/kg body weight and 60,000 IU of vitamin A. Blood samples were taken at time 0 and every hour until the 6th and every 2.5 hours until the 11th hour. Total plasma cholesterol (C) and TG, and C, TG, Apo B-100, Apo B-48, and retinyl palmitate (RP) in lipoprotein fractions were determined.
Results: Subjects with the APOA5*2 and APOA5*3 haplotypes had a higher area under the curve of total plasma TG (p=0.03), large triacylglycerol-rich lipoproteins (TRL)-TG (p=0.02), small TRL-TG (p=0.04), small TRL-C (p=0.04), large TRL-C (p=0.03), and small apoB100 (p=0.04) than subjects with the APOA5*1 haplotype.
Conclusions: Our findings show that the presence of the APOA5*2 and APOA5*3 haplotypes in the APOA5 gene are associated with a higher postprandial response which could be involved in the higher risk of CHD associated with the 56G and -1131C alleles.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |